
When a healthcare provider (HCP) diagnoses you with non-small cell lung cancer, they then need to determine the stage of the cancer. For many people, the numbers and letters that describe cancer may sound confusing—and possibly frightening.
With that in mind, here is an overview of what cancer staging means and how it works. If you have questions or concerns about your diagnosis, it is important to speak with your HCP.
What is cancer staging?
Staging describes how advanced a cancer is and whether it has spread beyond the initial tumor site. This helps your HCP plan your treatment and identify potential clinical trials for which you might be eligible. Staging also helps HCPs communicate with each other by providing a common language for discussing cancer.
Common staging conventions
Providers generally use the TNM system for staging non-small cell lung cancer. TNM describes the size and extent of the tumor (T), whether it's also present in regional (nearby) lymph nodes (N) and whether the cancer has metastasized (M) or spread.
Your HCP determines the stage of the cancer using the information gathered during physical exams. Imaging tests, blood tests, biopsies, and pathology reports all provide a piece of the puzzle. This is called clinical staging.
Some people undergo surgery, either to remove cancer and/or nearby lymph nodes, to see how much cancer is in their body, or to obtain a biopsy sample. The information gathered during surgery may be used to determine pathological staging, which is sometimes different from clinical staging.
TNM calculated by clinical staging is designated with a lowercase “c,” while TNM calculated by pathological staging is designated with a lowercase “p.”
Using the TNM data and other factors, your HCP will assign the cancer a staging number between 0 and IV.
- Stage 0 refers to very small tumors that are not in the deep tissues of the lungs or in any other parts of the body.
- Stage I is a small tumor that is limited to the lung where it started and has not spread to lymph nodes inside the lung.
- Stage II cancers are larger in size and may have spread to nearby lymph nodes inside the lung or into the chest wall.
- Stage III is when the lung cancer has spread to lymph nodes and surrounding structures of the body.
- Stage IV is when the lung cancer has metastasized and spread to other parts of the body.
Details on the cancer are included with the TNM stage number. For example, non-small cell lung cancer staged at IIB T3 N0 M0 is larger than 5 cm but smaller than 7 cm or has grown into the chest or has two distinct tumor nodules, but has not spread to lymph nodes or metastasized.
The stage of cancer does not change even if the cancer progresses; it's based on the stage at time of diagnosis.
Other ways to classify cancer
Tumor grade classifies cancer cells based on how abnormal they look under a microscope and how quickly they are likely to grow. Physicians assign tumor grade values based on the type of cancer. Grades progress from grade 1, least aggressive and slow growing, to grade 3, fast growing and aggressive.
Sources: International Association for the Study ... + 8
- International Association for the Study of Lung Cancer. IASLC Staging Project for Lung Cancer and Thymic Tumors. Accessed June 1, 2026.
- National Cancer Institute. Cancer Staging. October 14, 2022.
- Merck Manual. Diagnosis of Cancer: Staging. September 2024.
- American Cancer Society. Cancer Staging. September 10, 2024.
- LUNGevity Foundation. LUNGevity Overview. Accessed June 1, 2026.
- Cancer Research UK. Stages of Cancer. October 10, 2023.
- Cancer Treatment Centers of America. Lung Cancer Stages. January 27, 2023.
- National Cancer Institute. Non Small Cell Lung Cancer Treatment (PDQ). May 16, 2025.
- Kahya Y, Marım F, et al. Breaking: The New 9th Version TNM Classification for Lung Cancer is Now in Use. Thorac Res Pract. 2026 Jan 30;27(1):47-56.